A new trading day began on Friday, with Cassava Sciences Inc (NASDAQ: SAVA) stock price down -4.37% from the previous day of trading, before settling in for the closing price of $1.83. SAVA’s price has ranged from $1.15 to $42.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -40.61%. Meanwhile, its annual earnings per share averaged 62.33%. With a float of $41.98 million, this company’s outstanding shares have now reached $48.31 million.
Let’s determine the extent of company efficiency that accounts for 30 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cassava Sciences Inc (SAVA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cassava Sciences Inc is 13.11%, while institutional ownership is 32.96%. The most recent insider transaction that took place on Nov 29 ’24, was worth 15,480. In this transaction Chief Medical Officer of this company sold 4,000 shares at a rate of $3.87, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Chief Financial Officer sold 59,800 for $3.86, making the entire transaction worth $230,828. This insider now owns 11,500 shares in total.
Cassava Sciences Inc (SAVA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 62.33% per share during the next fiscal year.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Here are Cassava Sciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51
Technical Analysis of Cassava Sciences Inc (SAVA)
Looking closely at Cassava Sciences Inc (NASDAQ: SAVA), its last 5-days average volume was 1.85 million, which is a jump from its year-to-date volume of 1.6 million. As of the previous 9 days, the stock’s Stochastic %D was 12.02%.
During the past 100 days, Cassava Sciences Inc’s (SAVA) raw stochastic average was set at 31.58%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.79% in the past 14 days, which was lower than the 93.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8842, while its 200-day Moving Average is $9.1072. However, in the short run, Cassava Sciences Inc’s stock first resistance to watch stands at $1.8163. Second resistance stands at $1.8825. The third major resistance level sits at $1.9157. If the price goes on to break the first support level at $1.7169, it is likely to go to the next support level at $1.6837. Now, if the price goes above the second support level, the third support stands at $1.6175.
Cassava Sciences Inc (NASDAQ: SAVA) Key Stats
With a market capitalization of 84.54 million, the company has a total of 48,308K Shares Outstanding. Currently, annual sales are 0 K while annual income is -24,340 K. The company’s previous quarter sales were 0 K while its latest quarter income was -23,400 K.
